Literature DB >> 1810185

Susceptibility of Legionella pneumophila grown extracellularly and in human monocytes to indole-3-propionic acid.

F Mandelbaum-Shavit1, V Barak, K Saheb-Tamimi, N Grossowicz.   

Abstract

Indole-3-propionic acid (IPA), a phytohormone derivative, is a potent inhibitor of growth of Legionella pneumophila cultivated extracellularly in a chemically defined hypotonic medium and intracellularly in human monocytes. The inhibitory activity turns into bactericidal activity with increasing concentrations. The susceptibility of the microorganism to IPA was more evident in "fast-growing" cultures (under conditions of vigorous shaking) than in static cultures growing under an atmosphere of 5% CO2-95% air, which resulted in a decreased growth rate. The MIC, after incubation with the drug for 48 h and as determined by counting of the CFU, was 1.58 microM for fast-growing cultures and 2.64 microM for those grown under static conditions. The MBCs were 5.28 and 26.43 microM, respectively. Tryptophan (Trp) at 150 microM prevented the inhibition caused by 2.64 microM IPA, increased the MIC about 3-fold, and increased the MBC by 10-fold. The effect of Trp was less remarkable in "slow-growing" cultures. The susceptibility of L. pneumophila proliferating in human monocytes was markedly lower than that when it was cultivated extracellularly in the chemically defined hypotonic medium. The MIC after incubation for 48 h was 5.28 microM, and a decrease in viable count was achieved with 105.70 microM. The lower susceptibility was apparently due (at least partially) to the presence of Trp (24.50 microM) in the RPMI 1640 medium that was used for the monocyte cultures. The effect of IPA was time dependent, and prolonged exposure enhanced the bactericidal activity and turned the inhibitory dose into a bactericidal dose. The present data demonstrate that IPA is a potent anti-L. pneumophila factor, although it has a markedly lower activity against bacteria growing intracellularly compared with its activity against extracellularly proliferating microorganisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810185      PMCID: PMC245425          DOI: 10.1128/AAC.35.12.2526

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  The tryptophan synthetase system.

Authors:  C YANOFSKY
Journal:  Bacteriol Rev       Date:  1960-06

2.  Phytohormones as specific inhibitors of Legionella pneumophila growth.

Authors:  N Grossowicz
Journal:  Isr J Med Sci       Date:  1990-04

3.  Factors affecting growth of Legionella pneumophila in liquid media.

Authors:  J Barker; I D Farrell; J G Hutchison
Journal:  J Med Microbiol       Date:  1986-09       Impact factor: 2.472

4.  Amino acid requirements for Legionella pneumophila growth.

Authors:  M J Tesh; R D Miller
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

Review 5.  Tryptophan synthase: structure, function, and subunit interaction.

Authors:  E W Miles
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

6.  Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil.

Authors:  M A Horwitz
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

7.  Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

8.  Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.

Authors:  J L Vildé; E Dournon; P Rajagopalan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Growth of Legionnaires disease bacterium (Legionella pneumophila) in chemically defined medium.

Authors:  W J Warren; R D Miller
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

10.  Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors.

Authors:  N R Payne; M A Horwitz
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  4 in total

1.  Ammonia generation by tryptophan synthase drives a key genetic difference between genital and ocular Chlamydia trachomatis isolates.

Authors:  Shardulendra P Sherchand; Ashok Aiyar
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

2.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis.

Authors:  Dereje Abate Negatu; Yoshiyuki Yamada; Yu Xi; Mei Lin Go; Matthew Zimmerman; Uday Ganapathy; Véronique Dartois; Martin Gengenbacher; Thomas Dick
Journal:  mBio       Date:  2019-03-26       Impact factor: 7.867

Review 4.  Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease.

Authors:  Piotr Konopelski; Izabella Mogilnicka
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.